---
figid: PMC9661757__12964_2022_990_Fig2_HTML
pmcid: PMC9661757
image_filename: 12964_2022_990_Fig2_HTML.jpg
figure_link: /pmc/articles/PMC9661757/figure/Fig2/
number: Fig. 2
figure_title: ''
caption: JAK1 suppresses EC cell growth and migration. A Western blotting of the indicated
  proteins in WCLs (whole cell lysates) from six endometrial cancer lines. B Western
  blotting of the indicated proteins in WCLs from KLE and SPEC-2 cells expressing
  sh ctrl, JAK1-sh1, or JAK1-sh2. C, D CCK-8 cell proliferation analysis of KLE and
  SPEC-2 cells expressing sh ctrl, JAK1-sh1, or JAK1-sh2. Data are shown as the mean ± SD
  (n = 3). E, F Colony formation analysis of KLE and SPEC-2 cells expressing sh ctrl,
  JAK1-sh1, or JAK1-sh2. Data are shown as the mean ± SD (n = 3). Scale bar, 100 μm.
  G, H Transwell migration analysis of KLE and SPEC-2 cells expressing sh ctrl, JAK1-sh1,
  or JAK1-sh2. Data are shown as the mean ± SD (n = 3). Scale bar, 100 μm
article_title: JAK1 inactivation promotes proliferation and migration of endometrial
  cancer cells via upregulating the hypoxia-inducible factor signaling pathway.
citation: Qin Lin, et al. Cell Commun Signal. 2022;20:177.
year: '2022'

doi: 10.1186/s12964-022-00990-5
journal_title: 'Cell Communication and Signaling : CCS'
journal_nlm_ta: Cell Commun Signal
publisher_name: BioMed Central

keywords:
- Endometrial cancer
- JAK1
- HIF-1α
- HIF-2α
- Proliferation
- Migration

---
